Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
D000818:Animals; D001285:Atropine / Q000378:metabolism; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D002188:Cannabis / Q000378:metabolism; D002540:Cerebral Cortex / Q000166:cytology; D002746:Chlorpromazine / Q000378:metabolism; D002845:Chromatography; D003956:Dialysis; D013759:Dronabinol / Q000378:metabolism; D004355:Drug Stability; D004357:Drug Synergism; D006213:Hallucinogens / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008566:Membranes / Q000378:metabolism; D009186:Myelin Sheath / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013574:Synaptosomes / Q000201:enzymology / Q000378:metabolism; D013696:Temperature; D014316:Tritium
D006213:Hallucinogens; D014316:Tritium; D001285:Atropine; D013759:Dronabinol; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D002746:Chlorpromazine